Press monitoring

Edible batteries, sensors and actuators unlock robots designed to be eaten

17.6.2024   |   Press monitoring

Scientists have already made edible robotic components. The next challenge is integrating them together to create an entire robot snack that could be used in a wide range of applications, from delivering healthcare to monitoring the environment. Imagine ordering drone delivery for your takeout, and then, after eating your food, you eat the...

Continue


Engineered plants produce human milk sugars that could lead to healthier baby formula
Credit: foliat - Fotolia.com

Engineered plants produce human milk sugars that could lead to healthier baby formula

14.6.2024   |   Press monitoring

Worldwide, a majority of babies – approximately 75% – drink infant formula in their first six months of life, either as a sole source of nutrition or as a supplement to breastfeeding. But while formula provides essential food for growing babies, it currently does not replicate the full nutritional profile of breast milk. That's in part because...

Continue


Research team uses CRISPR/Cas9 to alter photosynthesis for the first time
Credit: contrastwerkstatt - Fotolia.com

Research team uses CRISPR/Cas9 to alter photosynthesis for the first time

12.6.2024   |   Press monitoring

A team from the Innovative Genomics Institute at the University of California, Berkeley (UCB) has produced an increase in gene expression in a food crop by changing its upstream regulatory DNA. While other studies have used CRISPR/Cas9 gene-editing to knock out or decrease the expression of genes, new research published in Science Advances is the...

Continue


Nanoparticles reprogram mouse immune systems to cope with allergens
Credit: Jezper - Fotolia.com

Nanoparticles reprogram mouse immune systems to cope with allergens

10.6.2024   |   Press monitoring

Two doses of allergen-encapsulating nanoparticles delivered intravenously prevented anaphylaxis during a food allergy test in mice, according to a study led by University of Michigan researchers. The results, published in Advanced Healthcare Materials, offer a potential path to improving the ease of allergy immunotherapies in humans which...

Continue


Chimeric nanomicelles show promise as alternative treatment for solid tumors

7.6.2024   |   Press monitoring

Cross-border scientific collaboration has developed an alternative for the treatment of solid tumors based on inhibition of the inflammatory tumor microenvironment (TME). Solid tumors are difficult to treat, partly owing to cells and substances in the TME that prevent drugs from penetrating and stop the patient's own immune system from combating...

Continue


New modified CRISPR protein can fit inside virus used for gene therapy

5.6.2024   |   Press monitoring

Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver it to target cells. Hongjian Wang and colleagues at Wuhan University, China, present these findings in the open-access journal PLOS Biology. Recent...

Continue


Study reveals promising technology for sepsis treatment using functional magnetic nanoclusters
Credit: fotoliaxrender - Fotolia.com

Study reveals promising technology for sepsis treatment using functional magnetic nanoclusters

3.6.2024   |   Press monitoring

A research team has introduced a novel technology capable of removing inflammation-triggering agents in extracorporeal blood. The team, led by Professors Joo Hun Kang and Jinmyoung Joo in the Department of Biomedical Engineering at UNIST, in collaboration with Professor Jae Hyuk Lee from Seoul National University Bundang Hospital, anticipates...

Continue


Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials
Credit: agsandrew - Fotolia.com

Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials

31.5.2024   |   Press monitoring

A pioneering once-a-day pill that regenerates nerve cell connections damaged by ALS has been FDA-approved for ongoing clinical trials. The drug is now being given to those with ALS and could be a watershed moment in the treatment of the fatal disease. Spinogenix, a clinical-stage biopharmaceutical company, has developed SPG302, a unique...

Continue


New antibiotic kills pathogenic bacteria, spares healthy gut microbes

29.5.2024   |   Press monitoring

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. The drug, called lolamicin, also warded off secondary infections with Clostridioides difficile, a common and dangerous hospital-associated...

Continue


Team develops an intelligent nanodevice based on a component of cinnamon essential oil as an antimicrobial agent

27.5.2024   |   Press monitoring

A team of researchers from the Universitat Politecnica de Valencia (UPV) and the CIBER de Bioingeniería, Biomaterials y Nanomedicine (CIBER-BBN) has developed an intelligent "nanokiller" based on a component of cinnamon essential oil (cinnamaldehyde) for use as an antimicrobial agent. So far, the new nanodevice has shown significant efficacy...

Continue


Page: 1 2 3 4 5 6 7 8 9   Next

 

OPPI, MPO, EU

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist